Skip to main content
Premium Trial:

Request an Annual Quote

Genentech Licenses Crohn's Disease GeneMap From Genizon

NEW YORK (GenomeWeb News) – Genentech has licensed Genizon Biosciences’ GeneMap of Crohn’s disease to support drug and diagnostics development, Genizon said today.
 
Under the agreement, Genizon will receive an undisclosed upfront payment, research funding, and milestone payments for each therapeutic developed through the collaboration.
 
GeneMap’s disease-associated genes were generated from a whole genome association study of 500 families from the Quebec Founder Population.
 
Financial details were not disclosed.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.